6-Butyl-6H-benzo[4,5]imidazo[1,2-d][1,2,4]triazolo[4,3-b][1,2,4]triazole-3-sulfonic acid

Catalog No. :
ACPRQT167
CAS No. :
1538594-15-8
Molecular Formula :
C13H14N6O3S
Molecular Weight :
334.36

IUPAC Name:6-butyl-6H-benzo[4,5]imidazo[1,2-d][1,2,4]triazolo[4,3-b][1,2,4]triazole-3-sulfonic acid

6-Butyl-6H-benzo[4,5]imidazo[1,2-d][1,2,4]triazolo[4,3-b][1,2,4]triazole-3-sulfonic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Butyl-6H-benzo[4,5]imidazo[1,2-d][1,2,4]triazolo[4,3-b][1,2,4]triazole-3-sulfonic acid
IUPAC Name6-butyl-6H-benzo[4,5]imidazo[1,2-d][1,2,4]triazolo[4,3-b][1,2,4]triazole-3-sulfonic acid
MDL No.MFCD27957246
Molecular FormulaC13H14N6O3S
Molecular Weight334.36
SMILESO=S(C1=NN=C2N1N=C3N(CCCC)C4=CC=CC=C4N32)(O)=O
InChI KeyVBTCWHRRCCZQBC-UHFFFAOYSA-N
Synonym6-butyl-6H-[1,2,4]triazolo[3',4':5,1][1,2,4]triazolo[4,3-a]benzimidazole-3-sulfonic acid;6H-1,2,4-Triazolo[4',3':1,5][1,2,4]triazolo[4,3-a]benzimidazole-3-sulfonic acid, 6-butyl-
CAS No.1538594-15-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACPRQT167 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPRQT167 route product structure diagram
    ACPRQT1671538594-15-8
Inquiry

2. ACPRQT167 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPRQT167 route product structure diagram
    ACPRQT1671538594-15-8
Inquiry

Comments (0)